CapsoVision, Inc. (CV) Stock

NASDAQ: CVHealthcare company in the medical devices industry, based in Saratoga, CA.

CapsoVision stock price chart

CV interactive chart →

CV stock quote & key statistics

CapsoVision earnings per share

Income →
Earnings per share

CapsoVision revenue & net income

Income →
RevenueNet income

CapsoVision annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$13.6M-$25.3M-$2.92
FY2024$11.8M-$19.9M—
FY2023$9.8M-$11.3M—

Fiscal year ending December 31. Source: company filings via EODHD.

About CapsoVision, Inc.

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).

It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals.

It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

CapsoVision stock FAQ

What is the CapsoVision stock ticker symbol?

CapsoVision, Inc. trades on the NASDAQ under the ticker symbol CV.

What sector and industry is CapsoVision in?

CapsoVision, Inc. is classified in the Healthcare sector, Medical Devices industry.

How many employees does CapsoVision have?

CapsoVision, Inc. has about 99 full-time employees.

What were CapsoVision's revenue and earnings last fiscal year?

CapsoVision reported revenue of $13.6M and net income of -$25.3M in fiscal 2025, with earnings per share of -$2.92. Revenue grew 15.3% from the prior year.

Is CapsoVision in the Russell 2000?

Yes. CapsoVision, Inc. (CV) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.

When did CapsoVision go public?

CapsoVision stock began trading on July 2, 2025.

Russell 2000 Medical Devices stocks

All Russell 2000 →